Merck, and Hanmi Pharmaceutical (Korea-based pharmaceutical company) have announced that the companies have entered in...
South Korean firm Samsung Biologics held an online ceremony to announce the launch of its proprietary cell line technolo...
Korean biotech company Macrogen has recently announced that it has obtained the CE marking for Europe's I...
South Korean firm PharmAbcine Inc. entered into a research collaboration with Wuxi Shuangliang Biotechnology (SLBio) to ...
Korean biotech, GC has applied for an investigational new drug application (IND) to conduct a Phase 2 clinical trial for...
South Korean firm Seegene, Inc. has announced that U.S. Food and Drug Administration (FDA) has further expanded the emer...
South Korean firm Samsung Biologics has announced a plan to expand its Drug Product (DP) capability in line with increas...
South Korea based Celltrion Group has announced the launch of its Phase I human clinical trial investigating a potential...
South Korea based Samsung Biologics recently announced strong financial results for its fiscal 2020 second quarter endin...
CGBIO, first medical healthcare company to successfully develop an aesthetic premium filler 'Giselleligne' using the R2 ...
VUNO Inc., South Korean artificial intelligence (AI) developer is showcasing its solutions at the European Con...
Bridge Biotherapeutics Inc., a clinical-stage biotech company headquartered in Seongnam, Republic of Korea and BaseLaunc...
South Korea based companies Samsung Biologics and ImmuneOncia Therapeutics held a signing ceremony for a contract to dev...
AVATAMED and CBmed, together with AIMEDBIO and Shimadzu Corporation, are collaborating in a Precision Cancer Project, le...
South Korea based Samsung Biologics has further expanded its partnership with STCube through an additional development a...
South Korean startup WellsCare, a member company of the Born2Global Centre (B2G), will be expanding its presence in the&...
Korea's Daewoong Pharmaceutical’s original botulinum toxin product Nabota is stepping up to expand its influence a...
Oculight announced the launching of OCU L&C, a fully-owned U.S. subsidiary of Oculight, in 2019 as the platform for ...
